FDA Adverse Event Injury Summary report: N

TACTICATH¿ CONTACT FORCE ABLATION CATHETER, SENSOR ENABLED¿

MDR report key: 18267837 · Received December 5, 2023

Report

Report Number
3005334138-2023-00546
Event Type
Injury
Date Received
December 5, 2023
Report Date
December 27, 2023
Manufacturer
ST. JUDE MEDICAL
Product Code
OAE
PMA / PMN Number
P130026
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. REVIEW OF THE DEVICE HISTORY RECORD WAS NOT POSSIBLE AS THE LOT NUMBER IS UNKNOWN. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.

Description of Event or Problem · 0

THE FOLLOWING WAS PUBLISHED IN HEARTRHYTHM CASE REPORTS (B)(4). ELSEVIER INC. ( (B)(6) 2023) "A SERIOUS COMPLICATION OF HIGH-POWER SHORT-DURATION RADIOFREQUENCY ATRIAL FIBRILLATION ABLATION ASSOCIATED WITH GENETIC HYPODYSFIBRINOGENEMIA"; KALABA, FRANK MD DURING AN ATRIAL FIBRILLATION ABLATION PROCEDURE, A PERICARDIAL EFFUSION OCCURRED WHICH REQUIRED A PERICARDIOCENTESIS, BLOOD TRANSFUSIONS, AND STERNOTOMY TO STABILIZE THE PATIENT. DURING A HIGH POWER SHORT DURATION RADIOFREQUENCY ABLATION (50 W FOR 10 SECONDS) OF THE LEFT ATRIAL APPENDAGE RIDGE NEAR THE JUNCTION OF THE ANTERIOR ASPECT OF THE LEFT SUPERIOR AND INFERIOR PULMONARY VEINS, AN IMPEDANCE RISE WAS NOTED AND A STEAM POP OCCURRED. HYPOTENSION WAS OBSERVED AND INTRACARDIAC ECHOCARDIOGRAPHY CONFIRMED A LARGE PERICARDIAL EFFUSION. PROTAMINE WAS ADMINISTERED AND A PERICARDIOCENTESIS WAS PERFORMED BUT THE EFFUSION WAS NOT RESOLVED. (B)(4) UNITS OF PACKED RED BLOOD CELLS, (B)(4) UNITS OF FRESH FROZEN PLASMA, AND 4 PACKS OF PLATELETS WERE ADMINISTERED. THE EFFUSION PERSISTED SO THE PATIENT WAS TRANSFERRED TO THE OPERATING ROOM FOR EMERGENT STERNOTOMY. A PERFORATION WAS LOCATED AT THE BASE OF THE LEFT ATRIAL APPENDAGE AND WAS REPAIRED. THE PATIENT RECOVERED AND WAS DISCHARGED HOME 3 DAYS LATER. THE PATIENT WAS PLACED ON LOW-DOSE HEPARIN AFTER THE SURGERY AND LATER TRANSITIONED TO ORAL ANTICOAGULATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2049240 TACTICATH¿ CONTACT FORCE ABLATION CATHETER, SENSOR ENABLED¿ CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION OAE ST. JUDE MEDICAL

Patients

Seq Age Sex Outcome Treatment
1 61 YR Male Required Intervention| L